CRISPR Therapeutics AG (CRSP)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 11:55AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 4.35B |
| Enterprise Value | 2.89B |
| Trailing P/E | 124.34 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.96 |
| Price/Book (mrq) | 2.31 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.79 |
| 52-Week Change 3 | -22.41% |
| S&P500 52-Week Change 3 | 26.27% |
| 52 Week High 3 | 91.10 |
| 52 Week Low 3 | 37.55 |
| 50-Day Moving Average 3 | 64.85 |
| 200-Day Moving Average 3 | 59.32 |
Share Statistics
| Avg Vol (3 month) 3 | 1.65M |
| Avg Vol (10 day) 3 | 1.41M |
| Shares Outstanding 5 | 84.92M |
| Implied Shares Outstanding 6 | 84.92M |
| Float 8 | 78.84M |
| % Held by Insiders 1 | 1.86% |
| % Held by Institutions 1 | 69.23% |
| Shares Short (Apr 30, 2024) 4 | 14.59M |
| Short Ratio (Apr 30, 2024) 4 | 11.22 |
| Short % of Float (Apr 30, 2024) 4 | 19.49% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 17.18% |
| Shares Short (prior month Mar 28, 2024) 4 | 14.76M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | -79.91% |
| Operating Margin (ttm) | -27,894.25% |
Management Effectiveness
| Return on Assets (ttm) | -7.97% |
| Return on Equity (ttm) | -11.02% |
Income Statement
| Revenue (ttm) | 271.71M |
| Revenue Per Share (ttm) | 3.40 |
| Quarterly Revenue Growth (yoy) | -99.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -278.89M |
| Net Income Avi to Common (ttm) | -217.14M |
| Diluted EPS (ttm) | -1.94 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.69B |
| Total Cash Per Share (mrq) | 21.1 |
| Total Debt (mrq) | 238.63M |
| Total Debt/Equity (mrq) | 12.67% |
| Current Ratio (mrq) | 17.81 |
| Book Value Per Share (mrq) | 23.52 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -159.42M |
| Levered Free Cash Flow (ttm) | -110.42M |
© 2024 Yahoo. All rights reserved.